Jump to content Jump to search
Symbolbild Neurone im Raum

Neuroscience Network Düsseldorf

The Neuroscience Network Düsseldorf is a collaborative research network in which basic and clinical neuroscientists from the Heinrich Heine University (HHU) Düsseldorf, the Research Centre Jülich, and the IUF - Leibniz Research Institute for Environmental Medicine Düsseldorf work together in multidisciplinary projects ranging from basic brain research to translational and clinical neuroscience.

A particular focus is placed on the investigation of disease-associated pathomechanisms in common diseases of the central nervous system, in particular multiple sclerosis, Alzheimer's and Parkinson's diseases, brain tumours, traumatic brain and spinal cord injury, and metabolic encephalopathies. These diseases constitute a major medical problem in our society and pose enormous socio-economic challenges. Thus, the common research aim of the participating groups is to improve the understanding of molecular, cellular and systemic mechanisms causing these diseases, and to translate novel experimental findings into better diagnostic tools and more effective therapies.

In addition, excellent research training opportunities for junior researchers from both medicine and the natural sciences are offered, including structured programmes that provide master students, as well as doctoral and postdoctoral researchers with the instruction, research experience and mentoring they need to become future leaders in disease-related neuroscience research.


News



RSS

Recent Publications

| NND-Publikationen

Lazaros Lazaridis et al., Acta Neuropathol Commun. 2026

Age-associated epigenomic heterogeneity in papillary tumors of the pineal region: a multicenter YoungNOA investigation.

| NND-Publikationen

Luana Cristina Camargo et al., Eur J Pharm Sci. [in press]

Pharmacokinetic properties of the clinical drug candidate PRI-002 with regard to genotype, sex, age, dose-dependence and…

| NND-Publikationen

Vlad Moisoiu et al., J Clin Invest. [in press]

Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.

| NND-Publikationen

Sara Mariotto et al., Neurol Neuroimmunol Neuroinflamm. 2026

Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.

| NND-Publikationen

Franz Felix Konen et al., Neurol Neuroimmunol Neuroinflamm. 2026

Kappa Free Light Chain for Diagnosis and Neurofilament Light Chain for Prognosis in Autoimmune Encephalitis.

| NND-Publikationen

Hussein Haidar et al., Front Cell Neurosci. 2026

Circadian rhythms of neuronal and astrocytic glutamate transporters in the suprachiasmatic nucleus of mice.

| NND-Publikationen

Olga Michalak et al., Int J Mol Sci. 2026

Virtual Screening, Synthesis and In Vitro Characterization of Histamine H4 Receptor Ligands Based on Pyrimidine…

| NND-Publikationen

Tina Jacob et al., Commun Chem. 2026

Liquid-liquid phase-separated tau colocalizes with and stabilizes Aβ oligomers.

| NND-Publikationen

Yulia Kostritskaia et al., Acta Neuropathol Commun. 2026

Overactive EAAT1 Cl- channels impair GABAergic tonic inhibition in SLC1A3-associated episodic ataxia.

Events & Dates